← The record

Amino Acid Formula With Vitamins And Minerals Without Phenylalanine And Tyrosine

Recommended MetabolicRestrictedNot applicable line 💬 consumer voice

Dietary management of tyrosinaemia.

4
Submissions
2014–20
On the record
ICER range
Cost-min
Cost basis

Decisions on record

5 decisions
  • Meeting Jul 2021 Recommended Tyrosinaemia
  • Meeting Mar 2012 Recommended Medicinal food no PSD
  • Meeting Jul 2007 Recommended Food no PSD
  • Meeting Mar 2003 Recommended A food for an inborn error of metabolism no PSD
  • Meeting Sep 2002 Recommended A food for inborn errors of metabolism no PSD

Access path

4 submissions · public record
  1. Nov 2014
    Deferred
  2. Jul 2016
    Recommended · restricted

    Evidence: Other → Cost-minimisation

  3. Mar 2017
    Recommended · restricted

    Comparator changed: TYR Express 15® → TYR Express15

  4. Jul 2020
    Recommended · restricted

    Comparator changed: TYR Express15 → TYR Express 20, TYR Cooler 20, TYR Lophlex LQ, XPHEN…

  5. PBS listing · Restricted
RecommendedDeferredNot recommended

From the public summary

Verbatim · PSD text · may span indications
PBAC outcome
7.1 The PBAC recommended the Restricted Benefit listing of amino acid formula with vitamins and minerals without phenylalanine and tyrosine, TYR Lophlex, for the management of tyrosinaemia (TYR) on a cost-minimisation basis per gram of protein with the nominated comparators.PSD · Jul 2020
7.2 The PBAC noted that the NPWP accepted TYR Express 20, TYR Cooler 20, TYR Lophlex LQ and XPHEN TYR Maxamum were relevant comparators.PSD · Jul 2020

Cost-effectiveness

Cost-minimisation analysis; no ICER calculated. PBAC recommended on a cost-minimisation basis per gram of protein with nominated comparators.

The PBAC recommended the Restricted Benefit listing of amino acid formula with vitamins and minerals without phenylalanine and tyrosine, TYR Lophlex, for the management of tyrosinaemia (TYR) on a cost-minimisation basis per gram of protein with the nominated comparators. PBAC · 2020
Cost-effectiveness accepted ×3

Decision context

PopulationPatients with tyrosinaemia aged 3 years or over (age restriction not required by PBAC due to specialist/nutritionist prescribing and product formulation).

Submission history

4 entries
DecidedOutcomeComparatorICEREvidence
Jul 2020 Recommended · restricted TYR Express 20, TYR Cooler 20, TYR Lophlex LQ, XPHEN TYR Maxamum Cost-minimisation · Cost-minimisation
Mar 2017 Recommended · restricted TYR Express15 Cost-minimisation · Cost-minimisation
Jul 2016 Recommended · restricted TYR Express 15® Cost-minimisation · Cost-minimisation
Nov 2014 Deferred Other

Consumer voice

Jul 2020

No consumer comments were received for this item.

The PBAC noted that no consumer comments were received for this item. Consumer comments · PSD

Similar precedents

By decision profile

Regulatory · TGA

Label narrower than PBS population — PBAC restricts to patients aged 3 years or over; TGA label does not specify age limits.